NOVAVAX INC (NVAX)

US6700024010 - Common Stock

3.98  -0.15 (-3.63%)

Premarket: 4 +0.02 (+0.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
475.6M
2,443.32%
1.146B
141.02%
1.982B
72.90%
1.034B
-47.83%
EBITDA
YoY % growth
-411.8M
-232.36%
-1.674B
-306.48%
-615.6M
63.22%
-120.36M
80.45%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-416.7M
-221.53%
-1.687B
-304.75%
-644.7M
61.78%
2.142B
432.25%
Operating Margin
-87.62%-147.13%-32.53%207.16%
EPS
YoY % growth
-6.79
-10.77%
-23.29
-243.00%
-8.40
63.93%
-4.37
48.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.51
77.48%
Revenue
Q2Q % growth
328.09M
-8.20%
EBITDA
Q2Q % growth
-66.917MN/AN/AN/AN/A
EBIT
Q2Q % growth
-42.655M
82.51%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
-1.26
41.40%
-1.870.6132.56%
Q2 2023
Q2Q % growth
0.58
108.88%
-1.411.99141.01%
Q1 2023
Q2Q % growth
-3.41
-233.20%
-3.530.123.43%
Q4 2022
Q2Q % growth
-2.28
79.61%
-0.94-1.34-142.97%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
187M
-74.54%
161.71M25.29M15.64%
Q2 2023
Q2Q % growth
424.4M
128.29%
243.94M180.46M73.98%
Q1 2023
Q2Q % growth
81M
-88.49%
89.364M-8.364M-9.36%
Q4 2022
Q2Q % growth
357.4M
60.85%
390.81M-33.41M-8.55%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-31.3% -31.3% 0% -163.35%
Revenue0% -18.96% 0% -25.18%